<SEC-DOCUMENT>0001819790-21-000008.txt : 20210331
<SEC-HEADER>0001819790-21-000008.hdr.sgml : 20210331
<ACCEPTANCE-DATETIME>20210331161503
ACCESSION NUMBER:		0001819790-21-000008
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20210331
ITEM INFORMATION:		Results of Operations and Financial Condition
FILED AS OF DATE:		20210331
DATE AS OF CHANGE:		20210331

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tarsus Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001819790
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				814717861
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39614
		FILM NUMBER:		21793466

	BUSINESS ADDRESS:	
		STREET 1:		15440 LAGUNA CANYON ROAD
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92618
		BUSINESS PHONE:		(949) 409-9820

	MAIL ADDRESS:	
		STREET 1:		15440 LAGUNA CANYON ROAD
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92618
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tars-20210331.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:c2a5dd4c-0714-4e6d-9d69-9dcdcf656cb9,g:98d4a9ec-f750-4120-90cd-b8b7f0f2ca8d,d:3d21f5dae21640a6afc90c3397e24961--><html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>tars-20210331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV84Ny9mcmFnOjQ5NTBmNDg0Y2M5NDRhZGNiYzZlY2ZjZWExYmExMGJiL3RhYmxlOjg2MTFmMTAzMWQ5NjQwNTliYTI5YmYxYmI0MmU5MWJjL3RhYmxlcmFuZ2U6ODYxMWYxMDMxZDk2NDA1OWJhMjliZjFiYjQyZTkxYmNfMS0xLTEtMS0yOTg_b380cf27-f4d0-42fb-b339-8ed41c756ec1">0001819790</ix:nonNumeric><ix:nonNumeric contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV84Ny9mcmFnOjQ5NTBmNDg0Y2M5NDRhZGNiYzZlY2ZjZWExYmExMGJiL3RhYmxlOjg2MTFmMTAzMWQ5NjQwNTliYTI5YmYxYmI0MmU5MWJjL3RhYmxlcmFuZ2U6ODYxMWYxMDMxZDk2NDA1OWJhMjliZjFiYjQyZTkxYmNfMi0xLTEtMS0yOTg_9bcd7321-1c1c-4348-9c92-d928f3f72806">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="tars-20210331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001819790</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-31</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd7aeb4c5d704f9d8df20d4892766cb8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001819790</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i3d21f5dae21640a6afc90c3397e24961_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">_______________</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGV4dHJlZ2lvbjpkYjBlMjVlMzJjNDI0MGI2YmY2MDViNGViYTE0ODUxOF8zMjk4NTM0ODg4MTE5_f903466c-47f0-4fee-952e-59cccb5c630b">8-K</ix:nonNumeric> </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Date of Report (date of earliest event reported): <ix:nonNumeric contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGV4dHJlZ2lvbjpkYjBlMjVlMzJjNDI0MGI2YmY2MDViNGViYTE0ODUxOF8zMjk4NTM0ODg4MTIx_49bf8a6d-c62f-4ef6-93b1-9e93b704bfab">March 31, 2021</ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">_______________</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ifd7aeb4c5d704f9d8df20d4892766cb8_D20200101-20201231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGV4dHJlZ2lvbjpkYjBlMjVlMzJjNDI0MGI2YmY2MDViNGViYTE0ODUxOF8zMjk4NTM0ODg4MTM2_d7f712e7-79c5-4106-929a-3d673ab10666">TARSUS PHARMACEUTICALS, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">_______________</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:37.699%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.699%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.584%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGFibGU6NWJmODNhZmVmMzZiNGQyOGIyOTZlNDFhYmIyM2QwMTgvdGFibGVyYW5nZTo1YmY4M2FmZWYzNmI0ZDI4YjI5NmU0MWFiYjIzZDAxOF8wLTAtMS0xLTIzMg_454db28c-34aa-4c2f-8582-9dfa10398d6a">Delaware</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:107%"><ix:nonNumeric contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGFibGU6NWJmODNhZmVmMzZiNGQyOGIyOTZlNDFhYmIyM2QwMTgvdGFibGVyYW5nZTo1YmY4M2FmZWYzNmI0ZDI4YjI5NmU0MWFiYjIzZDAxOF8wLTEtMS0xLTIzNA_8d9c456e-0e5b-4caf-bd57-859842044a7e">012-3456</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGFibGU6NWJmODNhZmVmMzZiNGQyOGIyOTZlNDFhYmIyM2QwMTgvdGFibGVyYW5nZTo1YmY4M2FmZWYzNmI0ZDI4YjI5NmU0MWFiYjIzZDAxOF8wLTMtMS0xLTIzNg_44c9fc83-54cf-47ed-92dd-225e7f4510e5">81-4717861</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">(I.R.S. Employer Identification No.)</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGV4dHJlZ2lvbjpkYjBlMjVlMzJjNDI0MGI2YmY2MDViNGViYTE0ODUxOF8zMjk4NTM0ODg4MTM3_a8c6577b-9b4a-466c-b8fd-94ddb7cc6f1a">15440 Laguna Canyon Road, Suite 160</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGV4dHJlZ2lvbjpkYjBlMjVlMzJjNDI0MGI2YmY2MDViNGViYTE0ODUxOF8zMjk4NTM0ODg4MTM4_b15ef8ce-1465-4e8d-be3f-b3a0298a866a">Irvine</ix:nonNumeric>, <ix:nonNumeric contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGV4dHJlZ2lvbjpkYjBlMjVlMzJjNDI0MGI2YmY2MDViNGViYTE0ODUxOF8zMjk4NTM0ODg4MTM5_b030d372-298f-4057-96a4-e313943500ff">CA</ix:nonNumeric> <ix:nonNumeric contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGV4dHJlZ2lvbjpkYjBlMjVlMzJjNDI0MGI2YmY2MDViNGViYTE0ODUxOF8zMjk4NTM0ODg4MTQx_3431066c-d0d7-4d08-97a4-a2e8f6ddbb7e">92618</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">(Address of principal executive offices, including Zip Code)</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant's telephone number, including area code: (<ix:nonNumeric contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGV4dHJlZ2lvbjpkYjBlMjVlMzJjNDI0MGI2YmY2MDViNGViYTE0ODUxOF8zMjk4NTM0ODg4MTU1_401b523a-d5f3-4447-b30f-2b1c3323246a">949</ix:nonNumeric>) <ix:nonNumeric contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGV4dHJlZ2lvbjpkYjBlMjVlMzJjNDI0MGI2YmY2MDViNGViYTE0ODUxOF8zMjk4NTM0ODg4MTY0_68374e6f-168a-4bff-8233-32d9a61377b3">409-9820</ix:nonNumeric></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.123%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:107%"><ix:nonNumeric contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGFibGU6NmRhMmY2OGQxOGRjNDIwNWIzMmM4ZmVhOTM0MDhlNjgvdGFibGVyYW5nZTo2ZGEyZjY4ZDE4ZGM0MjA1YjMyYzhmZWE5MzQwOGU2OF8wLTAtMS0xLTI0NA_d04ec5ab-71fe-4b49-ab65-1ba5f7913564">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:107%"><ix:nonNumeric contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGFibGU6NmRhMmY2OGQxOGRjNDIwNWIzMmM4ZmVhOTM0MDhlNjgvdGFibGVyYW5nZTo2ZGEyZjY4ZDE4ZGM0MjA1YjMyYzhmZWE5MzQwOGU2OF8yLTAtMS0xLTI0Ng_c32f8d8e-2020-4d2f-963c-1c9f63f2af9a">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"><ix:nonNumeric contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGFibGU6NmRhMmY2OGQxOGRjNDIwNWIzMmM4ZmVhOTM0MDhlNjgvdGFibGVyYW5nZTo2ZGEyZjY4ZDE4ZGM0MjA1YjMyYzhmZWE5MzQwOGU2OF80LTAtMS0xLTI0OA_ef05e46a-a49e-4665-9e17-c6901ec87829">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGFibGU6NmRhMmY2OGQxOGRjNDIwNWIzMmM4ZmVhOTM0MDhlNjgvdGFibGVyYW5nZTo2ZGEyZjY4ZDE4ZGM0MjA1YjMyYzhmZWE5MzQwOGU2OF82LTAtMS0xLTI1MA_8906027a-eb5d-48d1-a851-9179cc7d59da">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.690%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGFibGU6MjlkZDVjYjg3OWI1NDM4Mzk1YWE0NzE1ZDMyYjUzN2EvdGFibGVyYW5nZToyOWRkNWNiODc5YjU0MzgzOTVhYTQ3MTVkMzJiNTM3YV8xLTAtMS0xLTI3Ng_eb6350c3-3429-4824-aca0-94a8a5f787cb">Common Stock, $0.0001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGFibGU6MjlkZDVjYjg3OWI1NDM4Mzk1YWE0NzE1ZDMyYjUzN2EvdGFibGVyYW5nZToyOWRkNWNiODc5YjU0MzgzOTVhYTQ3MTVkMzJiNTM3YV8xLTEtMS0xLTI3Ng_9c615da6-12d3-40e5-bd0a-114d1db55961">TARS</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Nasdaq Global Market LLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonNumeric contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGFibGU6MjlkZDVjYjg3OWI1NDM4Mzk1YWE0NzE1ZDMyYjUzN2EvdGFibGVyYW5nZToyOWRkNWNiODc5YjU0MzgzOTVhYTQ3MTVkMzJiNTM3YV8xLTItMS0xLTI3NC90ZXh0cmVnaW9uOjI2YjVhNTc5MzE0YjRiMjA4NGUwMGVkNzYyMjBjYzVmXzMyOTg1MzQ4ODM0MTc_1846bc38-f7c5-4ddc-bc3d-e758f5d0b040">Nasdaq Global Select Market</ix:nonNumeric>)</span></div></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Emerging growth company <ix:nonNumeric contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGV4dHJlZ2lvbjpkYjBlMjVlMzJjNDI0MGI2YmY2MDViNGViYTE0ODUxOF8zMjk4NTM0ODg4MTY2_d7c94990-2e67-4389-ad4e-b8f68f96880b">&#9746;</ix:nonNumeric></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331" format="ixt:booleantrue" name="dei:EntityExTransitionPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGV4dHJlZ2lvbjpkYjBlMjVlMzJjNDI0MGI2YmY2MDViNGViYTE0ODUxOF8zMjk4NTM0ODg4MTY3_88b151ab-971f-40b0-964e-5569af655096">&#9746;</ix:nonNumeric></span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i3d21f5dae21640a6afc90c3397e24961_51"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 2.02 Results of Operations and Financial Condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 31, 2021, Tarsus Pharmaceuticals, Inc. (the &#8220;Company&#8221;) issued a press release, which, among other matters, sets forth the Company&#8217;s results of operations for the year ended December 31, 2020. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The foregoing information, including Exhibit 99.1, is being furnished under Item 2.02 and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 9.01 Financial Statements and Exhibits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(d)  Exhibits.</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:2.125%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.565%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.973%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.266%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.973%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.391%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Exhibit No.</span></div></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Description</span></div></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right;text-indent:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">99.1</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:1pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="exhibit991tarsus3312021pre.htm">Press Release dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="exhibit991tarsus3312021pre.htm">March 31, 2021</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt;text-indent:1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;text-indent:1pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cover Page Interactive Data File (embedded within XBRL document)</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i3d21f5dae21640a6afc90c3397e24961_60"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:right"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">SIGNATURE</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:2.425%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.242%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.585%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.242%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.371%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Date: March 31, 2021</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By:</span></div></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">/s/ </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Leo M. Greenstein</span></div></td></tr><tr><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-indent:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Leo M. Greenstein</span></div></td></tr><tr><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Chief Financial Officer</span></div></td></tr><tr><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">(Principal Financial Officer and Principal Accounting Officer)</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit991tarsus3312021pre.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i6d9b49ddee514ed0b322f3eba752be15_33"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><img alt="picture11.jpg" src="picture11.jpg" style="height:122px;margin-bottom:5pt;vertical-align:text-bottom;width:168px"></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Tarsus Pharmaceuticals, Inc. Reports Full-Year 2020 Financial Results and Business and Clinical Updates</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">Enrollment complete for Saturn-1, first TP-03 pivotal trial for the treatment of Demodex blepharitis&#59; initiation of Saturn-2 expected in Q2 2021 </font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">Strategic partnership with LianBio in March 2021 for TP-03 in Greater China provides Tarsus with $70 million expected during next 12 months and up to $130 million in future years, plus double-digit royalties and equity in LianBio </font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">Cash and cash equivalents of $168 million as of December 31, 2020 </font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%">IRVINE, Calif., March 31, 2021 (GLOBE NEWSWIRE)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> -- Tarsus Pharmaceuticals, Inc. (NASDAQ&#58; TARS), a late clinical-stage biopharmaceutical company whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced financial results and certain business and clinical updates for the year ended December 31, 2020. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;Since completing our successful IPO in October of last year, we continue to make important clinical progress with our lead program, TP-03, which is currently being evaluated in the Saturn-1 pivotal Phase 2b&#47;3 trial for Demodex blepharitis, a disease for which there are currently no FDA-approved treatments,&#8221; said Bobak Azamian, MD, PhD, CEO, Tarsus Pharmaceuticals, Inc. &#8220;Our recent strategic partnership with LianBio for TP-03 in Greater China also expands our global reach to the second largest healthcare market in the world, while also providing significant non-dilutive funding.  This will further allow for our advancement of pipeline, including TP-04 and TP-05, each focused on areas of high unmet medical need in MGD, rosacea, Lyme disease, and malaria.&#8221; </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Recent Business Highlights and Corporate Update&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:13.8pt">In March 2021, Tarsus announced its strategic partnership to develop and commercialize TP-03 in Greater China (PRC, Hong Kong, Taiwan, and Macau) for the treatment of Demodex blepharitis and Meibomian Gland Disease (MGD), eye conditions with significant unmet treatment needs. In this arrangement, LianBio obtained exclusive TP-03 development and commercialization rights to Greater China. In return, LianBio will (i) pay Tarsus $25 million by June 30, 2021 and up to $175 million in clinical, regulatory, and sales milestones, (ii) pay Tarsus tiered low double-digit royalties on sales of TP-03 in Greater China, and (iii) grant Tarsus a minority equity stake in LianBio Ophthalmology.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:107%">Tarsus expects to receive $70 million from these contractual milestones during the next 12 months.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:14.15pt">In December 2020, Tarsus had a Type C meeting with the United States Food and Drug Administration (FDA) for TP-03 in the treatment of Demodex blepharitis.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">This meeting confirmed the planned new drug application (NDA) pathway with respect to the data and information required in the NDA filing.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:14.15pt">In December 2020, Tarsus announced that it was added to the broad-market Russell 3000&#174; Index and the small-cap Russell 2000&#174; Index as part of its periodic rebalancing.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:14.15pt">Beginning in the fourth quarter of 2020, Tarsus further expanded its management team and expertise of its Board of Directors&#58;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.11pt">Appointed Bryan Wahl, M.D., J.D. as General Counsel. Dr. Wahl has over 15 years of broad legal experience, including significant intellectual property (IP), corporate, and transactional expertise.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.11pt">Appointed Dianne Whitfield as Chief Human Resources Officer. Ms. Whitfield has more than 20 years of experience in human resources, including over a decade of management and leadership experience in the life sciences industry.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.11pt">Appointed Wendy L. Yarno to the Board of Directors and its Audit Committee. Ms. Yarno has more than 30 years of experience in the biopharmaceutical industry, both as a public company director and product commercialization leader, including 26 years at Merck &#38; Co. Inc.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Full-Year 2020 Financial Results&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Full year net loss for 2020 was $26.8 million, compared to $4.7 million in 2019.  </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Full year research and development expenses for 2020 were $18.8 million, compared to $3.2 million in 2019. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Full year general and administrative expenses for 2020 were $8.2 million, compared to  $1.1 million in 2019. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">As of December 31, 2020, cash and cash equivalents were $168.1 million.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%">About Tarsus Pharmaceuticals, Inc.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Tarsus Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company that applies proven science and new technology to revolutionize treatment for patients, starting with eye care. It is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care, dermatology, and infectious disease prevention. Its lead product candidate, TP-03, is a novel therapeutic in Phase 2b&#47;3 that is being developed for the treatment of Demodex blepharitis and Meibomian Gland Disease.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Forward-Looking Statements</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute &#8220;forward-looking statements.&#8221; These statements include statements regarding the receipt by Tarsus of payments and achievement and timing of milestones under the terms of the collaboration, the ability of LianBio to commercialize TP-03 in the Greater China territory, the market size for TP-03, future events and Tarsus&#8217; plans for and the anticipated benefits of its product candidates including TP-03, the timing, objectives and results of the clinical studies and anticipated regulatory and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">development milestones and the quotations of Tarsus&#8217; management. The words, without limitation, &#8220;believe,&#8221; &#8220;contemplate,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;target,&#8221; &#8220;will&#8221; or &#8220;would&#8221; or the negative of these terms or other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these or similar identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors. Important factors that could cause actual results to differ materially from those in the forward-looking statements include&#58; Tarsus has incurred significant losses and negative cash flows from operations since inception and anticipates that it will continue to incur significant expenses and losses for the foreseeable future&#59; Tarsus may need to obtain additional funding to complete the development and any commercialization of its product candidates, if approved&#59; Tarsus is heavily dependent on the success of its lead product candidate, TP-03 for the treatment of Demodex blepharitis&#59; the COVID-19 pandemic may affect Tarsus&#8217; ability to initiate and complete preclinical studies and clinical trials, disrupt regulatory activities, disrupt manufacturing and supply chain or have other adverse effects on Tarsus&#8217; business and operations&#59; even if TP-03 or any other product candidate that Tarsus develops receives marketing approval, Tarsus may not be successful in educating eye care physician and the market about the need for treatments specifically for Demodex blepharitis and or other diseases or conditions targeted by Tarsus&#8217; products&#59; the development and commercialization of Tarsus products is dependent on intellectual property it licenses from Elanco Tiergesundheit AG&#59; Tarsus will need to develop and expand the company and Tarsus may encounter difficulties in managing its growth, which could disrupt its operations&#59; the sizes of the market opportunity for Tarsus&#8217; product candidates, particularly TP-03 for the treatment of Demodex blepharitis and MGD, have not been established with precision and may be smaller than estimated&#59; the results of Tarsus&#8217; earlier studies and trials may not be predictive of future results&#59; any termination or suspension of, or delays in the commencement or completion of, Tarsus&#8217; planned clinical trials could result in increased costs, delay or limit its ability to generate revenue and adversely affect its commercial prospects&#59; and if Tarsus is unable to obtain and maintain sufficient intellectual property protection for its product candidates, or if the scope of the intellectual property protection is not sufficiently broad, Tarsus&#8217; competitors could develop and commercialize products similar or identical Tarsus&#8217; product. Further, there are other risks and uncertainties that could cause actual results to differ from those set forth in the forward-looking statement and they are detailed from time to time in the reports Tarsus files with the Securities and Exchange Commission, including Tarsus&#8217; Form 10-K for the year ended December 31, 2020 filed with the SEC on March 31, 2021, which Tarsus incorporates by reference into this press release, copies of which are posted on its website and are available from Tarsus without charge. However, new risk factors and uncertainties may emerge from time to time, and it is not possible to predict all risk factors and uncertainties. Accordingly, readers are cautioned not to place undue reliance on these forward-looking statements. Any forward-looking statements contained in this press release are based on the current expectations of Tarsus&#8217; management team and speak only as of the date hereof, and Tarsus specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.</font></div><div style="margin-top:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.590%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.210%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Media Contact&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SuJin Oh</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Shop PR</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(917) 841-5213</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">soh&#64;shop-pr.com</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Investor Contact&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Patti Bank</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Westwicke Partners, an ICR company</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(415) 513-1284</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IR&#64;tarsusrx.com</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TARSUS PHARMACEUTICALS, INC.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(In thousands, except share and per share amounts)</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating expenses&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,826&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,162&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,172&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,136&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,998&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,298&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from operations before other income (expense) and income taxes</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26,998)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,298)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense)&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income (expense), net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on extinguishment of convertible notes</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(255)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(76)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other income (expense)</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(371)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for income taxes</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss and comprehensive loss</font></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26,811)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,670)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share attributable to common stockholders, basic and diluted</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.32)</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.98)</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average shares outstanding used in computing net loss per share attributable to common stockholders, basic and diluted</font></td><td colspan="2" style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,207,367&#160;</font></td><td style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,362,768&#160;</font></td><td style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TARSUS PHARMACEUTICALS, INC.</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BALANCE SHEETS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(In thousands, except share and par value amounts)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.474%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current assets&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168,129&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,952&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,486&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,655&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,030&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">548&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">688&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">171,972&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,316&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES, PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY (DEFICIT) </font></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current liabilities&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and other accrued liabilities</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,347&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">520&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued payroll and benefits</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,040&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">299&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,387&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">819&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">605&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,992&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">919&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Commitments and contingencies </font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Series A Preferred Stock, $0.0001 par value&#59; no shares authorized, issued and outstanding at December 31, 2020&#59; 1,575,030 shares authorized, issued and outstanding at December&#160;31, 2019&#59; liquidation preference of $3,650 at December&#160;31, 2019 </font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,564&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Series B Preferred Stock, $0.0001 par value&#59; no shares authorized, issued and outstanding at December 31, 2020&#59; 6,731,649 shares authorized and 6,674,909 shares issued and outstanding at December&#160;31, 2019&#59; liquidation preference of $60,010 at December&#160;31, 2019</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,838&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stockholders&#8217; equity (deficit)&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock, $0.0001 par value&#59; 10,000,000 and no shares authorized at December 31, 2020 and December 31, 2019, respectively&#59; no shares issued and outstanding at December 31, 2020 and December 31, 2019</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $0.0001 par value&#59; 200,000,000 shares authorized&#59; 20,502,576 shares issued and 20,323,201 outstanding, which excludes 179,375 shares subject to repurchase at December&#160;31, 2020&#59; 2,650,919 shares issued and 2,646,619 outstanding, which excludes 4,300 shares subject to repurchase at December&#160;31, 2019</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198,821&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated deficit</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,845)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,034)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total stockholders&#8217; equity (deficit) </font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165,980&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,005)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities, preferred stock and stockholders&#8217; equity (deficit) </font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">171,972&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,316&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>tars-20210331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c2a5dd4c-0714-4e6d-9d69-9dcdcf656cb9,g:98d4a9ec-f750-4120-90cd-b8b7f0f2ca8d-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:tars="http://tarsusrx.com/20210331" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://tarsusrx.com/20210331">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tars-20210331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tars-20210331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tars-20210331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tars-20210331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://tarsusrx.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>4
<FILENAME>tars-20210331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c2a5dd4c-0714-4e6d-9d69-9dcdcf656cb9,g:98d4a9ec-f750-4120-90cd-b8b7f0f2ca8d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://tarsusrx.com/role/Cover" xlink:type="simple" xlink:href="tars-20210331.xsd#Cover"/>
  <link:calculationLink xlink:role="http://tarsusrx.com/role/Cover" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>tars-20210331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c2a5dd4c-0714-4e6d-9d69-9dcdcf656cb9,g:98d4a9ec-f750-4120-90cd-b8b7f0f2ca8d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://tarsusrx.com/role/Cover" xlink:type="simple" xlink:href="tars-20210331.xsd#Cover"/>
  <link:definitionLink xlink:role="http://tarsusrx.com/role/Cover" xlink:type="extended" id="i672203a44b4642d0b5d04b8473134177_Cover"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>tars-20210331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c2a5dd4c-0714-4e6d-9d69-9dcdcf656cb9,g:98d4a9ec-f750-4120-90cd-b8b7f0f2ca8d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_DocumentType_ebf197fa-641f-4602-98a5-4cbdb28118ed_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_3cb14347-210c-432c-82b4-a0f0ede5c3d4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_a26d73a8-d57c-48b0-bc7e-e2868d17eb27_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_4a1e6218-4ac2-4fb8-bb13-004e9638c6a7_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_f18b3d42-2f80-40cd-a42d-76379b0c0a74_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_8e0f28df-dc16-4fed-af4a-3ccc943cbcf9_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_bf69653c-de36-4ba7-8421-730b1f201126_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_9a07b874-8277-4b3e-a8fe-04ddea498144_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_2c7de89f-3dc3-4169-82ac-4672e7c6d106_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_3fdc44fe-e040-4f65-8291-f3856812ff01_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_bfbfa140-1363-4bc3-be7f-afe0b6d88f48_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_4652879f-f1c0-455a-b16c-3e82de657ef9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_c8b92cef-f57d-4774-83dc-06ccb8d81b56_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_9f44e1b5-2f71-4047-bebb-d4f4d9aacf0a_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_cd08968d-1a4e-4806-adab-b7760483bdc3_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_863153d5-a359-421b-a6c0-9718c7f9e3ce_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_d1b2e739-c9a3-44c2-a9a0-88b83b0a6012_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_af083c9a-56f7-4d3a-8d83-35498c8123b4_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_2039330e-42bb-4466-91f4-090a81f3bb17_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_be487eb0-456a-41e2-be19-1967bcb9eb2d_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_5e4f36c1-d1b1-4b4f-9c72-d6785983f485_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_43c13846-616d-4040-99f6-9b0ac55b49f1_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_21af943c-a1df-488b-b1c9-df3532baf81e_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>tars-20210331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c2a5dd4c-0714-4e6d-9d69-9dcdcf656cb9,g:98d4a9ec-f750-4120-90cd-b8b7f0f2ca8d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://tarsusrx.com/role/Cover" xlink:type="simple" xlink:href="tars-20210331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://tarsusrx.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_946d6905-1a2e-4679-93c7-c20fd5fe21ba" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_fd717ba5-ae5a-4760-be03-b728ddea26ba" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_946d6905-1a2e-4679-93c7-c20fd5fe21ba" xlink:to="loc_dei_DocumentType_fd717ba5-ae5a-4760-be03-b728ddea26ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_5e9a8946-dbd6-4080-ab8b-9a8229853740" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_946d6905-1a2e-4679-93c7-c20fd5fe21ba" xlink:to="loc_dei_DocumentPeriodEndDate_5e9a8946-dbd6-4080-ab8b-9a8229853740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_f67bd73d-4bfa-4377-94d0-f1ac9672af09" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_946d6905-1a2e-4679-93c7-c20fd5fe21ba" xlink:to="loc_dei_EntityRegistrantName_f67bd73d-4bfa-4377-94d0-f1ac9672af09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_43b0c75e-d0a6-476d-b469-a69502cba41c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_946d6905-1a2e-4679-93c7-c20fd5fe21ba" xlink:to="loc_dei_EntityIncorporationStateCountryCode_43b0c75e-d0a6-476d-b469-a69502cba41c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_c543cd43-82d1-48ec-8770-d247fa97a0d2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_946d6905-1a2e-4679-93c7-c20fd5fe21ba" xlink:to="loc_dei_EntityFileNumber_c543cd43-82d1-48ec-8770-d247fa97a0d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_09884477-9951-4d91-b91c-5b9e3c8682cc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_946d6905-1a2e-4679-93c7-c20fd5fe21ba" xlink:to="loc_dei_EntityTaxIdentificationNumber_09884477-9951-4d91-b91c-5b9e3c8682cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_8f45696d-3dd1-4f78-888f-298bb703dce9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_946d6905-1a2e-4679-93c7-c20fd5fe21ba" xlink:to="loc_dei_EntityAddressAddressLine1_8f45696d-3dd1-4f78-888f-298bb703dce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_e5e1f126-e8c0-4099-9c7b-08e8f7bcc272" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_946d6905-1a2e-4679-93c7-c20fd5fe21ba" xlink:to="loc_dei_EntityAddressCityOrTown_e5e1f126-e8c0-4099-9c7b-08e8f7bcc272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_ee39975a-60e7-4d5b-b677-430f3e4c0a45" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_946d6905-1a2e-4679-93c7-c20fd5fe21ba" xlink:to="loc_dei_EntityAddressStateOrProvince_ee39975a-60e7-4d5b-b677-430f3e4c0a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_97825b16-e1ed-4d88-a048-f53f71be2784" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_946d6905-1a2e-4679-93c7-c20fd5fe21ba" xlink:to="loc_dei_EntityAddressPostalZipCode_97825b16-e1ed-4d88-a048-f53f71be2784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_6702bedc-5753-432a-95fa-c173be992c09" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_946d6905-1a2e-4679-93c7-c20fd5fe21ba" xlink:to="loc_dei_CityAreaCode_6702bedc-5753-432a-95fa-c173be992c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_434bc4b9-a1fc-42b8-9cb5-fff91ae78a35" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_946d6905-1a2e-4679-93c7-c20fd5fe21ba" xlink:to="loc_dei_LocalPhoneNumber_434bc4b9-a1fc-42b8-9cb5-fff91ae78a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_2fb41e50-86c9-45a5-9f54-378cf0eff811" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_946d6905-1a2e-4679-93c7-c20fd5fe21ba" xlink:to="loc_dei_WrittenCommunications_2fb41e50-86c9-45a5-9f54-378cf0eff811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_7541c822-76a3-4855-ad26-3df2666858f4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_946d6905-1a2e-4679-93c7-c20fd5fe21ba" xlink:to="loc_dei_SolicitingMaterial_7541c822-76a3-4855-ad26-3df2666858f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_67fd72a4-bc0a-401a-84ef-a18370b52844" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_946d6905-1a2e-4679-93c7-c20fd5fe21ba" xlink:to="loc_dei_PreCommencementTenderOffer_67fd72a4-bc0a-401a-84ef-a18370b52844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_1235c2bd-8100-4cfb-b1e4-0b777047a3e2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_946d6905-1a2e-4679-93c7-c20fd5fe21ba" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_1235c2bd-8100-4cfb-b1e4-0b777047a3e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_85676695-6061-4b5f-a158-f8009176327a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_946d6905-1a2e-4679-93c7-c20fd5fe21ba" xlink:to="loc_dei_Security12bTitle_85676695-6061-4b5f-a158-f8009176327a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_f52a73e2-23ef-4df9-9960-c2eed935025e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_946d6905-1a2e-4679-93c7-c20fd5fe21ba" xlink:to="loc_dei_TradingSymbol_f52a73e2-23ef-4df9-9960-c2eed935025e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_7e8deb0f-28e4-4c80-99a4-7b7d27bc0ae3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_946d6905-1a2e-4679-93c7-c20fd5fe21ba" xlink:to="loc_dei_SecurityExchangeName_7e8deb0f-28e4-4c80-99a4-7b7d27bc0ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_27d4c753-2de5-455a-8820-297b51cf957d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_946d6905-1a2e-4679-93c7-c20fd5fe21ba" xlink:to="loc_dei_EntityEmergingGrowthCompany_27d4c753-2de5-455a-8820-297b51cf957d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_16ebabc8-1b11-4723-9862-dcc0664ef57a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_946d6905-1a2e-4679-93c7-c20fd5fe21ba" xlink:to="loc_dei_EntityExTransitionPeriod_16ebabc8-1b11-4723-9862-dcc0664ef57a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_42a1f1d4-9400-414c-a0e0-9ed53b7d32ea" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_946d6905-1a2e-4679-93c7-c20fd5fe21ba" xlink:to="loc_dei_EntityCentralIndexKey_42a1f1d4-9400-414c-a0e0-9ed53b7d32ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_be9fd8d1-5184-42cc-9abd-f887276148dd" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_946d6905-1a2e-4679-93c7-c20fd5fe21ba" xlink:to="loc_dei_AmendmentFlag_be9fd8d1-5184-42cc-9abd-f887276148dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>picture11.jpg
<TEXT>
begin 644 picture11.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !Z *@# 2(  A$! Q$!_\0
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MZ5TX[#U,1-5J2YHM'+EV)I86FZ%9\LDSS_\ X*Z?\?/PX_W+S^<5?2G[*O\
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MB(#;N/'WL$9/'S9J*T*6'K4:J7+?==BZ%2MBJ%:DY<UMGW/&/^"6#!OV?=2
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0'#482YHP2?H@HHHK Z#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>tars-20210331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tars-20210331.xsd" xlink:type="simple"/>
    <context id="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819790</identifier>
        </entity>
        <period>
            <startDate>2021-03-31</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ifd7aeb4c5d704f9d8df20d4892766cb8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819790</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV84Ny9mcmFnOjQ5NTBmNDg0Y2M5NDRhZGNiYzZlY2ZjZWExYmExMGJiL3RhYmxlOjg2MTFmMTAzMWQ5NjQwNTliYTI5YmYxYmI0MmU5MWJjL3RhYmxlcmFuZ2U6ODYxMWYxMDMxZDk2NDA1OWJhMjliZjFiYjQyZTkxYmNfMS0xLTEtMS0yOTg_b380cf27-f4d0-42fb-b339-8ed41c756ec1">0001819790</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV84Ny9mcmFnOjQ5NTBmNDg0Y2M5NDRhZGNiYzZlY2ZjZWExYmExMGJiL3RhYmxlOjg2MTFmMTAzMWQ5NjQwNTliYTI5YmYxYmI0MmU5MWJjL3RhYmxlcmFuZ2U6ODYxMWYxMDMxZDk2NDA1OWJhMjliZjFiYjQyZTkxYmNfMi0xLTEtMS0yOTg_9bcd7321-1c1c-4348-9c92-d928f3f72806">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGV4dHJlZ2lvbjpkYjBlMjVlMzJjNDI0MGI2YmY2MDViNGViYTE0ODUxOF8zMjk4NTM0ODg4MTE5_f903466c-47f0-4fee-952e-59cccb5c630b">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGV4dHJlZ2lvbjpkYjBlMjVlMzJjNDI0MGI2YmY2MDViNGViYTE0ODUxOF8zMjk4NTM0ODg4MTIx_49bf8a6d-c62f-4ef6-93b1-9e93b704bfab">2021-03-31</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="ifd7aeb4c5d704f9d8df20d4892766cb8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGV4dHJlZ2lvbjpkYjBlMjVlMzJjNDI0MGI2YmY2MDViNGViYTE0ODUxOF8zMjk4NTM0ODg4MTM2_d7f712e7-79c5-4106-929a-3d673ab10666">TARSUS PHARMACEUTICALS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGFibGU6NWJmODNhZmVmMzZiNGQyOGIyOTZlNDFhYmIyM2QwMTgvdGFibGVyYW5nZTo1YmY4M2FmZWYzNmI0ZDI4YjI5NmU0MWFiYjIzZDAxOF8wLTAtMS0xLTIzMg_454db28c-34aa-4c2f-8582-9dfa10398d6a">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGFibGU6NWJmODNhZmVmMzZiNGQyOGIyOTZlNDFhYmIyM2QwMTgvdGFibGVyYW5nZTo1YmY4M2FmZWYzNmI0ZDI4YjI5NmU0MWFiYjIzZDAxOF8wLTEtMS0xLTIzNA_8d9c456e-0e5b-4caf-bd57-859842044a7e">012-3456</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGFibGU6NWJmODNhZmVmMzZiNGQyOGIyOTZlNDFhYmIyM2QwMTgvdGFibGVyYW5nZTo1YmY4M2FmZWYzNmI0ZDI4YjI5NmU0MWFiYjIzZDAxOF8wLTMtMS0xLTIzNg_44c9fc83-54cf-47ed-92dd-225e7f4510e5">81-4717861</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGV4dHJlZ2lvbjpkYjBlMjVlMzJjNDI0MGI2YmY2MDViNGViYTE0ODUxOF8zMjk4NTM0ODg4MTM3_a8c6577b-9b4a-466c-b8fd-94ddb7cc6f1a">15440 Laguna Canyon Road, Suite 160</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGV4dHJlZ2lvbjpkYjBlMjVlMzJjNDI0MGI2YmY2MDViNGViYTE0ODUxOF8zMjk4NTM0ODg4MTM4_b15ef8ce-1465-4e8d-be3f-b3a0298a866a">Irvine</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGV4dHJlZ2lvbjpkYjBlMjVlMzJjNDI0MGI2YmY2MDViNGViYTE0ODUxOF8zMjk4NTM0ODg4MTM5_b030d372-298f-4057-96a4-e313943500ff">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGV4dHJlZ2lvbjpkYjBlMjVlMzJjNDI0MGI2YmY2MDViNGViYTE0ODUxOF8zMjk4NTM0ODg4MTQx_3431066c-d0d7-4d08-97a4-a2e8f6ddbb7e">92618</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGV4dHJlZ2lvbjpkYjBlMjVlMzJjNDI0MGI2YmY2MDViNGViYTE0ODUxOF8zMjk4NTM0ODg4MTU1_401b523a-d5f3-4447-b30f-2b1c3323246a">949</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGV4dHJlZ2lvbjpkYjBlMjVlMzJjNDI0MGI2YmY2MDViNGViYTE0ODUxOF8zMjk4NTM0ODg4MTY0_68374e6f-168a-4bff-8233-32d9a61377b3">409-9820</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGFibGU6NmRhMmY2OGQxOGRjNDIwNWIzMmM4ZmVhOTM0MDhlNjgvdGFibGVyYW5nZTo2ZGEyZjY4ZDE4ZGM0MjA1YjMyYzhmZWE5MzQwOGU2OF8wLTAtMS0xLTI0NA_d04ec5ab-71fe-4b49-ab65-1ba5f7913564">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGFibGU6NmRhMmY2OGQxOGRjNDIwNWIzMmM4ZmVhOTM0MDhlNjgvdGFibGVyYW5nZTo2ZGEyZjY4ZDE4ZGM0MjA1YjMyYzhmZWE5MzQwOGU2OF8yLTAtMS0xLTI0Ng_c32f8d8e-2020-4d2f-963c-1c9f63f2af9a">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGFibGU6NmRhMmY2OGQxOGRjNDIwNWIzMmM4ZmVhOTM0MDhlNjgvdGFibGVyYW5nZTo2ZGEyZjY4ZDE4ZGM0MjA1YjMyYzhmZWE5MzQwOGU2OF80LTAtMS0xLTI0OA_ef05e46a-a49e-4665-9e17-c6901ec87829">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGFibGU6NmRhMmY2OGQxOGRjNDIwNWIzMmM4ZmVhOTM0MDhlNjgvdGFibGVyYW5nZTo2ZGEyZjY4ZDE4ZGM0MjA1YjMyYzhmZWE5MzQwOGU2OF82LTAtMS0xLTI1MA_8906027a-eb5d-48d1-a851-9179cc7d59da">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGFibGU6MjlkZDVjYjg3OWI1NDM4Mzk1YWE0NzE1ZDMyYjUzN2EvdGFibGVyYW5nZToyOWRkNWNiODc5YjU0MzgzOTVhYTQ3MTVkMzJiNTM3YV8xLTAtMS0xLTI3Ng_eb6350c3-3429-4824-aca0-94a8a5f787cb">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGFibGU6MjlkZDVjYjg3OWI1NDM4Mzk1YWE0NzE1ZDMyYjUzN2EvdGFibGVyYW5nZToyOWRkNWNiODc5YjU0MzgzOTVhYTQ3MTVkMzJiNTM3YV8xLTEtMS0xLTI3Ng_9c615da6-12d3-40e5-bd0a-114d1db55961">TARS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGFibGU6MjlkZDVjYjg3OWI1NDM4Mzk1YWE0NzE1ZDMyYjUzN2EvdGFibGVyYW5nZToyOWRkNWNiODc5YjU0MzgzOTVhYTQ3MTVkMzJiNTM3YV8xLTItMS0xLTI3NC90ZXh0cmVnaW9uOjI2YjVhNTc5MzE0YjRiMjA4NGUwMGVkNzYyMjBjYzVmXzMyOTg1MzQ4ODM0MTc_1846bc38-f7c5-4ddc-bc3d-e758f5d0b040">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGV4dHJlZ2lvbjpkYjBlMjVlMzJjNDI0MGI2YmY2MDViNGViYTE0ODUxOF8zMjk4NTM0ODg4MTY2_d7c94990-2e67-4389-ad4e-b8f68f96880b">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNkMjFmNWRhZTIxNjQwYTZhZmM5MGMzMzk3ZTI0OTYxL3NlYzozZDIxZjVkYWUyMTY0MGE2YWZjOTBjMzM5N2UyNDk2MV8xL2ZyYWc6ZGIwZTI1ZTMyYzQyNDBiNmJmNjA1YjRlYmExNDg1MTgvdGV4dHJlZ2lvbjpkYjBlMjVlMzJjNDI0MGI2YmY2MDViNGViYTE0ODUxOF8zMjk4NTM0ODg4MTY3_88b151ab-971f-40b0-964e-5569af655096">true</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140199566507752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">TARSUS PHARMACEUTICALS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">012-3456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">81-4717861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">15440 Laguna Canyon Road, Suite 160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Irvine<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92618<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">409-9820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TARS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001819790<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MG9A=;^(X%(:O9W^%A?9B5VI+'%(^1A0I3>D,FK;#$#HC[6HO3&+ :A)G':?
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M3]MO'FQUS?\,L*^!9LE(Q.<@9%UU0%=MM^[;"RW38O<[DQKVTL7IDC/P,?,
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M J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ W(%_4I>*NQS
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M4$L! A0#%     @ W(%_4@=!36*!    L0   !               ( !
M &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #<@7]2)XB4!.X    K @
M$0              @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4
M" #<@7]2F5R<(Q &  "<)P  $P              @ ', 0  >&PO=&AE;64O
M=&AE;64Q+GAM;%!+ 0(4 Q0    ( -R!?U(_@UM!<P0  $P1   8
M      " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M" #<@7]2GZ ;\+$"  #B#   #0              @ &V#   >&PO<W1Y;&5S
M+GAM;%!+ 0(4 Q0    ( -R!?U*7BKL<P    !,"   +              "
M 9(/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( -R!?U*JQ"(6,P$  "("   /
M              "  7L0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #<
M@7]2)!Z;HJT   #X 0  &@              @ ';$0  >&PO7W)E;',O=V]R
M:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #<@7]299!YDAD!  #/ P  $P
M            @ ' $@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 )
+ #X"   *%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="tars-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tarsusrx.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tars-20210331.htm">tars-20210331.htm</File>
    <File>exhibit991tarsus3312021pre.htm</File>
    <File>tars-20210331.xsd</File>
    <File>tars-20210331_cal.xml</File>
    <File>tars-20210331_def.xml</File>
    <File>tars-20210331_lab.xml</File>
    <File>tars-20210331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tars-20210331.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 2,
   "dts": {
    "calculationLink": {
     "local": [
      "tars-20210331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "tars-20210331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "tars-20210331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "tars-20210331_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tars-20210331_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "tars-20210331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "tars",
   "nsuri": "http://tarsusrx.com/20210331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tars-20210331.htm",
      "contextRef": "i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://tarsusrx.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "tars-20210331.htm",
      "contextRef": "i69aae7b322784ef1bdce30f8bfb847d8_D20210331-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tarsusrx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tarsusrx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tarsusrx.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tarsusrx.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tarsusrx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tarsusrx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tarsusrx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tarsusrx.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tarsusrx.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tarsusrx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tarsusrx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tarsusrx.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tarsusrx.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tarsusrx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tarsusrx.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tarsusrx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tarsusrx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tarsusrx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tarsusrx.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tarsusrx.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tarsusrx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tarsusrx.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://tarsusrx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001819790-21-000008-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001819790-21-000008-xbrl.zip
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M@?[P\O3V[/3? ##5$W9W>G/[T6"<.: YS-)(#K+ VX(UI></-4%PQ]T>>^R
MJP(,#D-2B1"UI 6>!7#:9;';%1%HD["5 G#?=WJDCL)EH26%:PFZX8I'%@FK
MXP)!VCUL(Q /GA,CWL&,4QB):NX##J)\&4!'  ?46%)IT8.!\T 8T(#->]"R
MZ\70A0THG-BN(&6[++#Y'+2QF;9AR<Q!X\F&]7$:E9P)UX;FQB0XNXP(OXX4
M?'A7S>=S)[<2::V-%%+,BP,6QI8%\V[%#CN_OD)@NK(B#R<&:NIP,%PX:8,]
MXILNO!8+Y$V7WPLFN^@E<+1\"<6 L>T Z4C<P X<\"C59=XU%#Q#:QT)B@*B
M8L5! 'P$D6@*')( W(BYMF9(\L2,]BTGR#%(6[[YX5VQ<E)(&=()=A-EV9:A
MP#?P$=4M- N #4*2ZMWUV->STPQ()TJF/9"VT"#JF2<LY!)\':_)[]GI?X$Y
MW 6%/S-@0/"CWK@R9FN:9L(5D"00"-K ^R?MVPR+!BU[:+5 8$,B=-N!L:%T
M<YRC1]0+!3#-!CX&;0&L!._>B3JH'\# X!X44U/YT0L<F]CB"-6R,IC(DA"L
MC&S!5&#(KN>"64.E? "*QBX^D&7LKB.1XPXP(@Z0O-"&XSW2\'%HW'X W1.)
MA^-+7Z"4&M"]Y<34"\ZR2-J'OY4,1M,@& %VH.& B9'MZ(!D:UCI"IND#N&%
M?(%OP(K "X'XW& 7O:Y(V&]0TUT.E) \F[!TJGW5P4'D^<J=3MG;O^(PDJW>
MJ@WN-#N3QVCI1@E,W]'^#O<<O*]];B\ 143,5DXWH?D\OL/P7&:['#ZWD5$9
M1[2BXT(Y(8H$-'2CXXQ9]:/Y:7(GNP"KEP#Y-UZ7N_-&,C/@K7SRVM;U9(@B
M9B%+%#A/>Z1]2!B8(0D\FZSXH+*V>!".YRLCY'6[(D"#A=9O"@@<7M_4#?;=
M P7Z%_S _N0C A.V\(-;//XX=Y"AWA&RZ2&VL6\._GVFT?,05 M< S*O@"B4
MQM @G\8'I9:#GLCN9P$ 80380Q!PMTTX8/0QSFNB!0;2B%\ !B$BBYJMI@8U
M-$H1%08%2@> <D-DH0X#@89CT W!TZ'\"#3O)6QYGR_U'=-FC_T>NX(5<MI[
M2[O\E5+:Y4^L'6"-:,?@+'E!3Y$\!*\WQ$<!;3U050-Z'.X2W)8 YHKH."5,
M@#Y4,\"FR6Q7?4'+T#2852!/(F;0M>L%&&'H0 .\(S34@W#CRN]$'>YTR<O*
M+A5\I',ZOJ=26L>! #H [\:R/,E;.M&2&[S"FR'Z=^.O/)$84C\[P0"9VB+3
M! +=9W@+B'3,G4?>"P]>*!DU!H0O9 K&,"=7&:1M5+@:*C?9$J@TZ6BV%7A=
M5/I0>6T!MZ(8[.1 ,),P%X%A.-0=EXDAPZ'Q/C7O5S0;J_*%UVXLBEFSI*U%
M/Y# (*)O,#K@-'-VU_,%JX.;(P81#G+L#U>BBWP;473RU?-L0H2S(&ZS4QM$
M79*)04DX!+?VX[ ?.8\QR*Z20/.9<?;ZX3'YK0EU05%:,NBB\P\$\L'\H5'"
ML-1&NF+@"J"OB'J)1(48M - H]@"00]J9.)X@QO&B2?2!=IWM;E"4 X&L0VT
M F&I@S[T&LB]7.9IK\]+Z?/  03K"V%7Q!XAFH$V\(H2F6;@<3NCX[*;. P%
M."P%&/J'=V:E> (^#>HHRA1%=A#+.!F+^_U'\V./AN1?HH:CU^G#/#V(ET ,
M(4[$7$A*[O8RL#(9^ *>O>LBHF@U;WD8%+._8V"&RJL,B482,JM87H<($!1Q
MY2BS2/"NRAV#S0\ FT7"T2\>#VP"<$ 5"[S0<';D-QK5#HV_DE\G'RG,_?"N
M5LGE7Y>/T/$X'TV<^*GO>])%._LEZ$% ])-WP./_D3W+&NQW^(GZ]4U ] :.
M51V4&Y0P"R8X2P^" 0<'_@'8:I;4V@#RB52<.:(-KQ W*?V93H.D@RGLW'&$
M<MW\P$/N]]CA^34$8E82\JM8(,*U97#R:'%Y("C3?;D]Z^=C_9E$-X#][,BH
M)85C(],A!A,M]CT&'<5U4-!N"[RPJQ:P30#[?T# .W@>Y:#K!0)QWP7%'PC#
M0  0*#K47) TEY8)$B,.X;#%;=+]%#@@\S'#JG,(PVTB^#BR)9(\>P@7[1A<
MPPF!WUXP%A.,G\*U>^PBR_[D@>LE-GP<D943"&!]"LR, "BZ71E%0B@Y42\/
MRTAAJHR0ES"V#)/PU& 08G=00#GSXR8XJ_T5&EN/A@8#2&+'5C0AG:($*2UZ
M^;(>"_@L/^#A>_;A7:%Z M/(4E9[6Q*H3]4Q/,-N#OR?H>FM76U>WR6:J#;D
M$B'YU>*9"[ZMXX5J28UX@7[P^WPYVU\B-I38!LHS?E_,5M*YMWS.K&4GQ"Y/
M^*9[WCS-&S ^@E+7B!+IY"NB$+@W::;A"MI[LSJ5:X5L?IQK>Z:MGFEM[8'2
MVGHJ]?,@IK*M.N#-,-> HUESS[:78]OIY.(70Y7-3*R?T9I6K@XXL])DT7SV
M<P;@+KF<N#Z'@%(&ITTOCF8NV*^U8F-F)0$NI"U8HD-))\I@ AR\>/$-^(81
MC9*6_2D3@ODGO>J/K8-V4)5("%8&T4NOTNL5Q=0*/ZWL<RM EX$S6CU$%<*$
M"?=IEM!C)-H>>,E#0=.@$ A<VBZ/:&)&DI(5&"ICI9Y>WO1ANC C5"X8>]@O
M6E&.,KPD;8JU=?D*<< %*CI#(P'$'*U.H61?J(M;M$W%8J05K,DNE[M;L]Y]
M]8)'")$R%YYWCR2A)0RJLUFKO@V&H>(LB5J" AH(AP2$$U[H6D^U^$8Q$Y5\
M0L=)9$6+ %AWA,@--AJC,= _CS)\X:"70+2!#$@!D,T(HG>MHM"ZZT6@ 2&$
M:Z3"+4X-=GD/5RB 8U$,FJ^KB5J:G(XFYZ"'?HW+':T"AND)HHZ(R:-!H:0%
M13_"%7&-0UBSPWOJ67(TK(X$6>YG("+9I41%*[W"&(/-UU(.&AAJM85). Y0
M4RU/&72)-Z6#B]7P1+),#1@QI0 "7Q@N@H#?0%EH#1YOZ@PZLG^P[F7T>??0
MGX6:'-+)K)QH-K9TD$S# D"PI$_5:$UPLUI2U;,2F(UB0SA2RU10@U&4,9C7
M_ LQYT&7 2<EB E-DO*Y,((6]#/I[@=U!G1KOS0_O#3_FE"1#HQ2TIX(S=^Q
MIY&!ZC>&1&R0M\NB6F+5G0VJC38/T<4!68FT6FC];H+%A/[Z-8CZ,J[IBZZ/
M/L"D6UBD.7X]=NS1BS!XV9W0B *XT:N8^'+'V@!@&KN$Y!J]B/HU=LV+T.IR
M9^Q&@)5]XVT$WE\3!A9V)DTNPJ+'L6>Q#"BY!+J>7,4&4I=5641;Q5%*2<,^
MC@4)G ._'$X+-V@KB.<(X(I.*J22&/> D673D=K ;4PP _!Y$/JYX\QXF,HY
MN()!7 @:C"+IB;PQ%*PL.U5+!PG8H FQ9:L%0T>FHRHXO:14!$NX(4K#%6Z$
MNQX6!G=F#83RC*III- #."SH40UJ@M%P>0%6?XU>4K:.)!( -$;S.CQ2+(6;
M/5"]L#9U=-K(Z;KVI*:"KF/-KSVTT(()*:W"?:93(-9RO,=0=8RK+UJO0ZGR
ML9;P*6TZ#-;A8(47*\[21=/4^5#/_1"=\OAJ&(EO"/\"BP4'=U ;+[4-2,\&
MN4G><924T*%7K?<7)K6YVHZJ74E4ES!24X?.R7@B>*J1 ]>WQ9(BZ:'A@,?4
M$?P!4!;Z\ 7%^UC*1FO5JL8\:7:F<[W@GBA\LG[UG_.SC%ECM'[:!4<<:<-;
MZ.6/('#B:1 S:#>52$H+%8U DR<:X_Y%JC<'.D#D$,3@)*4M,QIX&5$@DMP&
MR(]1ZE6U%94(QK0#PNH@QV"N'8X0HXJF;8B&0+P%#9TJ 8>'/[1+82"1BA3H
MV2![%!G)CTD<SS%B*QG5K-,R$2:59*%VH6C$Q&LL=4R+'<!44Z2W#L!4!/3
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MW$UJK1J?RC)P4L/A,/(0,4;QK#9P)55Y"3FI"S/U:O&S)@7/.3";[@)<0GN
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M#M(VQBYQFULUZ%^KZ_G.U=L:UK?Z;/ ,4$L#!!0    ( -R!?U*>!5IM?0$
M +X"   5    =&%R<RTR,#(Q,#,S,5]C86PN>&ULE5+;CML@$'W/5U#ZVC'8
M<2ZVXJS45)4JI2_9KG9?,> 8Q88(R-K[]S5DLU5OJOHR:&;.F3,7-G=CWZ%G
M:9TRNL)I0C&2FANA]+'"#]\^PQK?;6>SS3N IX^'/?ID^*67VJ.=E<Q+@0;E
M6_0HI#NAQIH>/1I[4L\,8!M).W-^L>K8>I31+/TU:TN>L840.0>Z2G/(Y5)
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M<F4N:'1M4$L! A0#%     @ W(%_4K!'E-3^%0  "HP  !$
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M<RTR,#(Q,#,S,5]L86(N>&UL4$L! A0#%     @ W(%_4LB-2K7A!@  >S,
M !4              ( !:40  '1A<G,M,C R,3 S,S%?<')E+GAM;%!+!08
1    !P ' -8!  !]2P     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
